Network demands US drug patent be vetoed (Bangkok Post) Nearly

Network demands US drug patent be vetoed (Bangkok Post)
Nearly 50 members of the Thai Network of People Living with HIV Aids yesterday lobbied the Commerce Ministry and the Intellectual Property Department to reject US-based GlaxoSmithKline’s (GSK) request for patent registration of an HIV medicine known as COMBID. Network chairman Kamol Upakaew pointed out COMBID is not a brand-new anti-HIV medication but a combination of two drugs, AZT and 3TC,